204 related articles for article (PubMed ID: 36859530)
1. Honokiol suppresses the aberrant interactions between renal resident macrophages and tubular epithelial cells in lupus nephritis through the NLRP3/IL-33/ST2 axis.
Ma Q; Xu M; Jing X; Qiu J; Huang S; Yan H; Yin L; Lou J; Zhao L; Fan Y; Qiu P
Cell Death Dis; 2023 Mar; 14(3):174. PubMed ID: 36859530
[TBL] [Abstract][Full Text] [Related]
2. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
He J; Sun M; Tian S
Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
[TBL] [Abstract][Full Text] [Related]
3. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
4. Role of vitamin D/VDR nuclear translocation in down-regulation of NF-κB/NLRP3/caspase-1 axis in lupus nephritis.
Huang J; An Q; Ju BM; Zhang J; Fan P; He L; Wang L
Int Immunopharmacol; 2021 Nov; 100():108131. PubMed ID: 34536747
[TBL] [Abstract][Full Text] [Related]
5. Ursolic acid alleviates lupus nephritis by suppressing SUMO1-mediated stabilization of NLRP3.
Chen L; Li F; Ni JH; Hao YX; Feng G; Shen XY; You Y
Phytomedicine; 2024 Jul; 130():155556. PubMed ID: 38810552
[TBL] [Abstract][Full Text] [Related]
6. Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome.
Peng X; Yang T; Liu G; Liu H; Peng Y; He L
Int Immunopharmacol; 2018 Dec; 65():448-457. PubMed ID: 30388519
[TBL] [Abstract][Full Text] [Related]
7. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
Li X; Wang M; Hong H; Luo C; Liu Z; Yang R
Immunol Res; 2018 Aug; 66(4):521-527. PubMed ID: 30047025
[TBL] [Abstract][Full Text] [Related]
8. GBP5 Inhibition Ameliorates the Progression of Lupus Nephritis by Suppressing NLRP3 Inflammasome Activation.
Liu N; Gao Y; Liu Y; Liu D
Immunol Invest; 2023 Jan; 52(1):52-66. PubMed ID: 36175170
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
Front Immunol; 2021; 12():584414. PubMed ID: 33717066
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 slows the progression of lupus nephritis by regulating the NLRP3 inflammasome through ROS/TRPM2/Ca
Tian J; Huang T; Chen J; Wang J; Chang S; Xu H; Zhou X; Yang J; Xue Y; Zhang T; Fan W; Wang Y
Clin Exp Med; 2023 Nov; 23(7):3465-3478. PubMed ID: 37261640
[TBL] [Abstract][Full Text] [Related]
11. Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
Zhao J; Zhang H; Huang Y; Wang H; Wang S; Zhao C; Liang Y; Yang N
Int Immunopharmacol; 2013 Sep; 17(1):116-22. PubMed ID: 23770281
[TBL] [Abstract][Full Text] [Related]
12. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway.
Chen XC; Wu D; Wu HL; Li HY; Yang C; Su HY; Liu ZJ; Huang XR; Lu X; Huang LF; Zhu SP; Pan QJ; An N; Liu HF
Lupus Sci Med; 2022 Apr; 9(1):. PubMed ID: 35414608
[TBL] [Abstract][Full Text] [Related]
13. S1P/S1PR1 axis promotes macrophage M1 polarization through NLRP3 inflammasome activation in Lupus nephritis.
Tian J; Chang S; Wang J; Chen J; Xu H; Huang T; Wang J; Kang J; Fan W; Wang Y
Mol Immunol; 2023 Aug; 160():55-66. PubMed ID: 37379683
[TBL] [Abstract][Full Text] [Related]
14. Accelerated, severe lupus nephritis benefits from treatment with honokiol by immunoregulation and differentially regulating NF-κB/NLRP3 inflammasome and sirtuin 1/autophagy axis.
Yang SR; Hsu WH; Wu CY; Shang HS; Liu FC; Chen A; Hua KF; Ka SM
FASEB J; 2020 Oct; 34(10):13284-13299. PubMed ID: 32813287
[TBL] [Abstract][Full Text] [Related]
15. Blockade of Notch1 Signaling Alleviated Podocyte Injury in Lupus Nephritis Via Inhibition of NLRP3 Inflammasome Activation.
Wu D; Jiang T; Zhang S; Huang M; Zhu Y; Chen L; Zheng Y; Zhang D; Yu H; Yao G; Sun L
Inflammation; 2024 Apr; 47(2):649-663. PubMed ID: 38085465
[TBL] [Abstract][Full Text] [Related]
16. Pim-1 as a Therapeutic Target in Lupus Nephritis.
Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
[TBL] [Abstract][Full Text] [Related]
17. P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.
Zhao J; Wang H; Dai C; Wang H; Zhang H; Huang Y; Wang S; Gaskin F; Yang N; Fu SM
Arthritis Rheum; 2013 Dec; 65(12):3176-85. PubMed ID: 24022661
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation.
Guo C; Fu R; Zhou M; Wang S; Huang Y; Hu H; Zhao J; Gaskin F; Yang N; Fu SM
J Autoimmun; 2019 Sep; 103():102286. PubMed ID: 31133359
[TBL] [Abstract][Full Text] [Related]
19. Lentivirus-mediated knockdown of FcγRI (CD64) attenuated lupus nephritis via inhibition of NF-κB regulating NLRP3 inflammasome activation in MRL/lpr mice.
Zhang H; Liu L; Li L
J Pharmacol Sci; 2018 Aug; 137(4):342-349. PubMed ID: 30190171
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CEBPB Attenuates Lupus Nephritis via Regulating Pim-1 Signaling.
Wang X; Cheng W; Chen X; Gong Y; Wang G; Zhang X; Qi Y
Mediators Inflamm; 2022; 2022():2298865. PubMed ID: 36248187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
